Literature search results

299 articles were found.

The following terms were included: Neuro-, 神経に関する

• 2020, Cui X, Ren W, Zheng Z, Li J
  Repetitive Transcranial Magnetic Stimulation Improved Source Memory and Modulated Recollection-Based Retrieval in Healthy Older Adults [med. app.]
  Front Psychol 11: 1137
• 2020, Gogeascoechea A, Kuck A, van Asseldonk E, Negro F, Buitenweg JR, Yavuz US, Sartori M
  Interfacing With Alpha Motor Neurons in Spinal Cord Injury Patients Receiving Trans-spinal Electrical Stimulation [med. app.]
  Front Neurol 11: 493
• 2020, Shah PP, White T, Khalafallah AM, Romo CG, Price C, Mukherjee D
  A systematic review of tumor treating fields therapy for high-grade gliomas [review]
  J Neurooncol 148 (3): 433-443
• 2020, Shi W, Blumenthal DT, Oberheim Bush NA, Kebir S, Lukas RV, Muragaki Y, Zhu JJ, Glas M
  Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice [med. app.]
  J Neurooncol 148 (3): 489-500
• 2020, Iseger TA, van Bueren NER, Kenemans JL, Gevirtz R, Arns M
  A frontal-vagal network theory for Major Depressive Disorder: Implications for optimizing neuromodulation techniques [review]
  Brain Stimul 13 (1): 1-9
• 2020, Patel R, Ashcroft J, Darzi A, Singh H, Leff DR
  Neuroenhancement in surgeons: benefits, risks and ethical dilemmas [basics]
  Br J Surg 107 (8): 946-950
• 2020, Xue SS, Zhou CH, Xue F, Liu L, Cai YH, Luo JF, Wang Y, Tan QR, Wang HN, Peng ZW
  The impact of repetitive transcranial magnetic stimulation and fluoxetine on the brain lipidome in a rat model of chronic unpredictable stress [med. app.]
  Prog Neuropsychopharmacol Biol Psychiatry 102: 109946
• 2020, Stein Y, Udasin IG
  [details] Electromagnetic hypersensitivity (EHS, microwave syndrome) - Review of mechanisms [review]
  Environ Res 186: 109445
• 2020, Mostafavi SA, Khaleghi A, Mohammadi MR
  [details] Noninvasive brain stimulation in alcohol craving: A systematic review and meta-analysis [review]
  Prog Neuropsychopharmacol Biol Psychiatry 101: 109938
• 2020, Kaur M, Michael JA, Hoy KE, Fitzgibbon BM, Ross MS, Iseger TA, Arns M, Hudaib AR, Fitzgerald PB
  Investigating high- and low-frequency neuro-cardiac-guided TMS for probing the frontal vagal pathway [med. app.]
  Brain Stimul 13 (3): 931-938
• 2020, Kim CY, Paek SH, Nam DH, Chang JH, Hong YK, Kim JH, Kim OL, Kim SH
  Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial [med. app.]
  J Neurooncol 146 (3): 399-406
• 2020, Lok E, San P, Liang O, White V, Wong ET
  Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastoma [tech./dosim.]
  J Neurooncol 147 (1): 125-133
• 2020, Arora Y, Chowdhury SR
  Cortical Excitability through Anodal Transcranial Direct Current Stimulation: a Computational Approach [tech./dosim.]
  J Med Syst 44 (2): 48
• 2020, Hung YY, Yang LH, Stubbs B, Li DJ, Tseng PT, Yeh TC, Chen TY, Liang CS, Chu CS
  [details] Efficacy and tolerability of deep transcranial magnetic stimulation for treatment-resistant depression: A systematic review and meta-analysis [review]
  Prog Neuropsychopharmacol Biol Psychiatry 99: 109850
• 2020, Davis FG, Smith TR, Gittleman HR, Ostrom QT, Kruchko C, Barnholtz-Sloan JS
  Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995-2015 [comment]
  Neuro Oncol 22 (2): 301-302
• 2020, Moffa AH, Martin D, Alonzo A, Bennabi D, Blumberger DM, Benseñor IM, Daskalakis Z, Fregni F, Haffen E, Lisanby SH, Padberg F, Palm U, Razza LB, Sampaio BJr, Loo C, Brunoni AR
  Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: An individual patient data meta-analysis [review]
  Prog Neuropsychopharmacol Biol Psychiatry 99: 109836
• 2020, Teti Mayer J, Chopard G, Nicolier M, Gabriel D, Masse C, Giustiniani J, Vandel P, Haffen E, Bennabi D
  Can transcranial direct current stimulation (tDCS) improve impulsivity in healthy and psychiatric adult populations? A systematic review [review]
  Prog Neuropsychopharmacol Biol Psychiatry 98: 109814
• 2020, Civile C, Cooke A, Liu X, McLaren R, Elchlepp H, Lavric A, Milton F, McLaren IPL
  The effect of tDCS on recognition depends on stimulus generalization: Neuro-stimulation can predictably enhance or reduce the face inversion effect [med. app.]
  J Exp Psychol Anim Learn Cogn 46 (1): 83-98
• 2019, Mitra S, Mehta UM, Binukumar B, Venkatasubramanian G, Thirthalli J
  [details] Statistical power estimation in non-invasive brain stimulation studies and its clinical implications: An exploratory study of the meta-analyses [review]
  Asian J Psychiatr 44: 29-34
• 2019, Jami AS, Guo X, Kulkarni P, Henin SE, Liu A, Chen Z
  Tracking Changes in Brain Network Connectivity under Transcranial Current Stimulation [med. app.]
  2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Berlin, Germany. IEEE: pp. 6430-6433; ISBN 978-1-5386-1312-2
• 2019, Lee H, Lee JS, Chung Y, Jung WR, Seong Kang J, Seo DW, Shon YM, Na DL, Joon Kim S
  A minimally invasive wirelessly powered brain stimulation system for treating neurological disorders [tech./dosim.]
  2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Berlin, Germany. IEEE: pp. 6141-6144; ISBN 978-1-5386-1312-2
• 2019, Treviranus GRS
  Mast cell autocrinicity near cerebral arterial wall "reverse glymphatic flow" as prime target of electromagnetic effects [tech./dosim.]
  Psychiatr Danub 31 Suppl 3: 357-370
• 2019, Thomas AA, Rauschkolb PK
  Tumor treating fields for glioblastoma: should it or will it ever be adopted? [basics]
  Curr Opin Neurol 32 (6): 857-863
• 2019, He Y, Sun W, Leung PS, Chow YT
  [details] Effect of Static Magnetic Field of Electric Vehicles on Driving Performance and on Neuro-Psychological Cognitive Functions [med./bio.]
  Int J Environ Res Public Health 16 (18)
• 2019, Toms SA, Kim CY, Nicholas G, Ram Z
  Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial [med. app.]
  J Neurooncol 141 (2): 467-473